March 31, 2026—The Food and Drug Administration granted 510(k) clearance to Roche’s Cobas c 703 and Cobas ISE Neo analytical units. As part of the Cobas Pro integrated solutions, the units are designed to help address laboratory challenges, including staff shortages, limited space, and growing test volumes. The Cobas c 703 delivers up to 2,000 tests per hour and offers 70 reagent positions. The Cobas ISE Neo delivers up to 1,800 tests per hour and reduces hands-on time through automated maintenance. Both systems offer monthly operator maintenance. With Cobas Pro integrated solutions, the required sample volume per test has been reduced by 43 percent on average compared with previous-generation systems, and the plastic generated per test result has been reduced by up to 78 percent due to smaller reagent pack sizes and higher number of tests per pack.
Webinars and Sponsored Roundtables — Register Now
Thursday, August 20, 2026. 12 PM-1:30 PM ET
Hear from an expert in HER2 IHC whose work has contributed to current scoring guidelines.
Webinar presenter Josef Ruschoff, MD, PhD, Former Chief Medical Officer and Co-Founder of Targos, Senior Consultant of Discovery Life Sciences, Kassel, Germany.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
To be rescheduled to a future date
Learn about digital pathology technology that is future-ready, yet practical for today’s
laboratory needs.
Webinar presenters Scott Hammond, Senior Systems Consultant, Digital Pathology Division, Wexner Medical Center, Department of Pathology, and Ursula Hofer, Imaging Technologist, Pathology Digital Imaging Lab, Wexner Medical Center, Department of Pathology, and Sandra Banky, PA(ASCP), Director of Operations, Wexner Medical Center, Department of Pathology.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY